Home » All » स्टॉक अंदाज » Zhengye Biotechnology Holding Limited Class A Ordinary Shares Forecast

Zhengye Biotechnology Holding Limited Class A Ordinary Shares Forecast: Tomorrow, Week, Month, 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -3.10%Market Cap $43.62M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$0.9319 ▲ +1.24%	Yesterday	$0.9157 ▼ -0.52%	Tomorrow's Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) setup is anchored to $0.9205 and targets $0.9319 (+1.24%). The near-term read is upside; watch $0.9481 / $0.8929 because daily realized volatility is about 6.38%.
Tomorrow's Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) setup is anchored to $0.9205 and targets $0.9319 (+1.24%). The near-term read is upside; watch $0.9481 / $0.8929 because daily realized volatility is about 6.38%.
Week	$0.9559 ▲ +3.85%	Last Week	$0.9056 ▼ -1.62%	The 7-day Zhengye Biotechnology Holding Limited Class A Ordinary Shares model moves from $0.9056 to $0.9559 (+3.85%). It gives upside momentum context for this stock, so breaks around $0.9481 / $0.8929 matter more than a single tick.
The 7-day Zhengye Biotechnology Holding Limited Class A Ordinary Shares model moves from $0.9056 to $0.9559 (+3.85%). It gives upside momentum context for this stock, so breaks around $0.9481 / $0.8929 matter more than a single tick.
Month	$0.9960 ▲ +8.20%	Last Month	$0.8888 ▼ -3.44%	The 1-month Zhengye Biotechnology Holding Limited Class A Ordinary Shares target is $0.9960 (+8.20%), compared with the live reference near $0.9205. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Zhengye Biotechnology Holding Limited Class A Ordinary Shares target is $0.9960 (+8.20%), compared with the live reference near $0.9205. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$1.06 ▲ +14.72%	Last Year	$0.8636 ▼ -6.18%	The 1-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares scenario points to $1.06 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares scenario points to $1.06 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$1.20 ▲ +30.00%	5 Years Ago	$0.8045 ▼ -12.60%	The 5-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares view is $1.20 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares view is $1.20 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$0.9319▲ +1.24%

Yesterday$0.9157▼ -0.52%

Tomorrow's Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) setup is anchored to $0.9205 and targets $0.9319 (+1.24%). The near-term read is upside; watch $0.9481 / $0.8929 because daily realized volatility is about 6.38%.

Week$0.9559▲ +3.85%

Last Week$0.9056▼ -1.62%

The 7-day Zhengye Biotechnology Holding Limited Class A Ordinary Shares model moves from $0.9056 to $0.9559 (+3.85%). It gives upside momentum context for this stock, so breaks around $0.9481 / $0.8929 matter more than a single tick.

Month$0.9960▲ +8.20%

Last Month$0.8888▼ -3.44%

The 1-month Zhengye Biotechnology Holding Limited Class A Ordinary Shares target is $0.9960 (+8.20%), compared with the live reference near $0.9205. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$1.06▲ +14.72%

Last Year$0.8636▼ -6.18%

The 1-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares scenario points to $1.06 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$1.20▲ +30.00%

5 Years Ago$0.8045▼ -12.60%

The 5-year Zhengye Biotechnology Holding Limited Class A Ordinary Shares view is $1.20 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$0.9205	Mid
Daily Change	-3.10%	Below
Volatility Cap	20.0%	Mid
Confidence	64%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$0.9205

Daily Change-3.10%

Market Cap$43.62M

Sourcenasdaq-screener

Current	$0.9205	Daily Change	-3.10%
Market Cap	$43.62M	Source	nasdaq-screener

Support & Resistance Levels

$0.8929Support 1

$0.9205Current

$0.9481Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$0.9205Live reference price

Used as the anchor for generated forecast calculations.

Next Month$0.9960Model projection+8.20%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

64%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

64%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in ZYBT today

Bullish Scenario

$0.9665

+5.00% from current

Target Price$0.9665

ScenarioUpside momentum

Probability56%

Base Scenario

$0.9960

+8.20%

Target Price$0.9960

ScenarioCapped drift

Probability64%

Bearish Scenario

$0.8745

-5.00% from current

Target Price$0.8745

ScenarioVolatility drawdown

Probability36%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 67/100

24H drift+1.24%

7D drift+3.85%

30D drift+8.20%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 65/100

1M outlook+8.20%

1Y outlook+14.72%

5Y outlook+30.00%

Frequently Asked Questions

Q What is the Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Zhengye Biotechnology Holding Limited Class A Ordinary Shares is projected near $0.9319 versus the current reference around $0.9205. That implies a modeled move of +1.24% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for ZYBT?

The weekly Zhengye Biotechnology Holding Limited Class A Ordinary Shares model points to $0.9559, which maps to an expected drift of +3.85% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Zhengye Biotechnology Holding Limited Class A Ordinary Shares 1-month and 1-year targets?

The Zhengye Biotechnology Holding Limited Class A Ordinary Shares 1-month target is $0.9960 (+8.20%), while the 1-year target is $1.06 (+14.72%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Zhengye Biotechnology Holding Limited Class A Ordinary Shares 5-year scenario differ from short-term rows?

The Zhengye Biotechnology Holding Limited Class A Ordinary Shares long-horizon scenario sits near $1.20 with a modeled change of +30.00%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are ZYBT support and resistance zones right now?

For Zhengye Biotechnology Holding Limited Class A Ordinary Shares, nearest resistance is around $0.8929, while nearest support is around $0.9481. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Zhengye Biotechnology Holding Limited Class A Ordinary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.